We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Aid for People Affected by Tsunami

By HospiMedica staff writers
Posted on 25 Jul 2005
Two major programs to address the critical care and other healthcare needs of people in Indonesia and Thailand affected by the tsunami have been announced by a humanitarian organization named Project HOPE (Health Opportunities for People Everywhere, Millwood, VA, USA) along with Genzyme Corp. More...
(Cambridge, MA, USA).

The first project is a one-year program designed to improve the national level of pediatric critical care nursing skills in Thailand. In collaboration with the Chiang Mai University Faculty of Nursing there, 55 nurses from hospitals serving the tsunami-affected areas will be trained with a standardized curriculum, resulting in certification. These trained nurses will then train peer nurses at their hospitals, raising the level of pediatric critical care nursing across Thailand.

A second project is a three-year commitment to re-equip and provide professional health training in order to re-establish quality medical service at Zaineol Abidin University Hospital in Bande Aceh (Indonesia), which lost 50% of its staff and most of its equipment and supplies in the tsunami. Doctors and nurses from Massachusetts General Hospital (Boston, USA) have volunteered with Project HOPE to restore medical services at the hospital and to provide training for the new hospital staff. During the first year, the focus will be on the pulmonary/infectious disease unit and obstetrical/gynecological care.

Genzyme will provide a three-year contribution totaling U.S.$1 million. "We wanted to contribute to the rebuilding effort in line with our corporate philosophy of creating constructive solutions to global health problems,” observed Henri Termeer, chairman and CEO of Genzyme.






Related Links:
Project HOPE
Genzyme Corp.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.